WHO validates Sinovac COVID-19 vaccine for emergency use - EXCELSIO | News & Information excelsio.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from excelsio.net Daily Mail and Mail on Sunday newspapers.
The World Health Organisation (WHO) on Tuesday validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and .
2nd LD: WHO validates China s Sinovac COVID-19 vaccine for emergency use
Xinhua
02 Jun 2021, 02:30 GMT+10
GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use. WHO recommends the vaccine for use in people 18 years and older, in a two-dose schedule with a spacing of two to four weeks, according to a statement. The efficacy results showed that the Sinovac vaccine prevented symptomatic disease in 51 percent of those vaccinated, and prevented severe COVID-19 and hospitalization in 100 percent of the studied population, according to the WHO s Strategic Advisory Group of Experts on Immunization (SAGE).
A Covid-19 vaccine by China's Sinovac Biotech has been approved for emergency use by the World Health Organization, adding a globally recognised vote of confidence to a jab that's been at the forefront of China's vaccine exports worldwide. The WHO announced its decision to clear the vaccine, dubbed CoronaVac, for an emergency-use license on Tuesday, making it the second vaccine from a Chinese drug maker to receive the listing in less than a.